Literature DB >> 21805247

Genetic and functional characterization of PCSK1.

Hélène Choquet1, Pieter Stijnen, John W M Creemers.   

Abstract

PC1/3 is a neuroendocrine-specific member of the mammalian subtilisin-like proprotein convertase family. This seven-member family is involved in the endoproteolytic cleavage of a large number of precursor proteins including prohormones, proneuropeptides, zymogens, and proreceptors. PC1/3 is synthesized as a zymogen, proPC1/3, and its propeptide is rapidly and autocatalytically cleaved in the endoplasmic reticulum. The mature protein is sorted and stored in dense-core secretory vesicles, together with its substrates. Compound-inactivating mutations in the PCSK1 gene, which encodes PC1/3, cause monogenic obesity. Furthermore, the contribution of two common nonsynonymous variants in PCSK1 to polygenic obesity risk has recently been established. Additional rare variants have been identified in non-consanguineous extremely obese Europeans but functional characterization has not yet been described. Sequencing efforts of larger cohorts of obese patients might reveal more variants conferring risk of obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805247     DOI: 10.1007/978-1-61779-204-5_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3.

Authors:  Stephanie L Dillon; Danielle M Williamson; Johannes Elferich; David Radler; Rajendra Joshi; Gary Thomas; Ujwal Shinde
Journal:  J Mol Biol       Date:  2012-06-25       Impact factor: 5.469

2.  Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum.

Authors:  Francieli Rohden; Cintia S Costa; Thais O Hammes; Rogério Margis; Alexandre V Padoin; Cláudio C Mottin; Regina Maria Guaragna
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

Review 3.  Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals.

Authors:  Kevin T Nead; Aihua Li; Mackenzie R Wehner; Binod Neupane; Stefan Gustafsson; Adam Butterworth; James C Engert; A Darlene Davis; Robert A Hegele; Ruby Miller; Marcel den Hoed; Kay-Tee Khaw; Tuomas O Kilpeläinen; Nick Wareham; Todd L Edwards; Göran Hallmans; Tibor V Varga; Sharon L R Kardia; Jennifer A Smith; Wei Zhao; Jessica D Faul; David Weir; Jie Mi; Bo Xi; Samuel Canizales Quinteros; Cyrus Cooper; Avan Aihie Sayer; Karen Jameson; Anders Grøntved; Myriam Fornage; Stephen Sidney; Craig L Hanis; Heather M Highland; Hans-Ulrich Häring; Martin Heni; Jessica Lasky-Su; Scott T Weiss; Glenn S Gerhard; Christopher Still; Melkaey M Melka; Zdenka Pausova; Tomáš Paus; Struan F A Grant; Hakon Hakonarson; R Arlen Price; Kai Wang; Andre Scherag; Johannes Hebebrand; Anke Hinney; Paul W Franks; Timothy M Frayling; Mark I McCarthy; Joel N Hirschhorn; Ruth J Loos; Erik Ingelsson; Hertzel C Gerstein; Salim Yusuf; Joseph Beyene; Sonia S Anand; David Meyre
Journal:  Hum Mol Genet       Date:  2015-03-17       Impact factor: 6.150

4.  PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.

Authors:  Chia-Lin Chou; Tzu-Ju Chen; Cheng-Yi Lin; Sung-Wei Lee; Shih-Chang Wang; Shou-Sheng Chu; Ching-Chieh Yang
Journal:  Onco Targets Ther       Date:  2020-04-15       Impact factor: 4.147

5.  Selection signature analysis implicates the PC1/PCSK1 region for chicken abdominal fat content.

Authors:  Hui Zhang; Xiaoxiang Hu; Zhipeng Wang; Yuandan Zhang; Shouzhi Wang; Ning Wang; Li Ma; Li Leng; Shengwen Wang; Qigui Wang; Yuxiang Wang; Zhiquan Tang; Ning Li; Yang Da; Hui Li
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.